As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers.
The US FDA has cleared the first updates to the algorithm of the Omnipod 5 automated insulin delivery (AID) system (Insulet ...
The FDA cleared an updated algorithm for a hybrid closed-loop insulin delivery system that permits users to set a lower ...
Zacks Investment Research on MSN
PODD stock benefits from FDA approval of Omnipod 5's enhancements
Insulet Corporation PODD recently received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. These updates to the Omnipod 5 algorithm set a new ...
While insulin pumps and continuous glucose monitors have improved the lives of many Type 1 diabetes patients, some still cannot maintain steady control. Implantable insulin pumps offer another option ...
The Omnipod 5 worn in a swimming pool. [Image courtesy of Insulet] Insulet (Nasdaq:PODD) today revealed plans for its innovation pipeline, which includes the next-generation Omnipod 6 system. At the ...
In the past couple of years, an onslaught of new wearable breast pumps have been brought to market. The Eufy Wearable Breast Pump S1 Pro is one of these new models, but it manages to stand out from ...
A year after the county medical examiner ruled Keith Bach’s death in the San Diego Central Jail a homicide due to neglect, questions persist over how the 63-year-old’s insulin pump — which he relied ...
It can be difficult to wear an insulin pump or other diabetes device on your body. Use these tips to help manage your use of this technology and avoid any hiccups that might arise. Share on Pinterest ...
Children using advanced hybrid closed-loop insulin pumps achieved better glucose control, yet most failed to follow dietary and exercise guidelines, highlighting that technology alone cannot replace ...
A Prescription Drug User Fee Act target date of May 29, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback